$15.63
-1.22-7.24%
At close: Sep 8, 5:00 PM EST
$15.54
-1.31-7.77%
Pre-Market: 4:01 AM EST
NovoCure Ltd
NVCRNASDAQ
NovoCure Earnings & Forecasts
NovoCure (NVCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NovoCure Guidance
NovoCure (NVCR) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided revenue in the range of $710M - $725M for the period.
Compared to prior guidance, NovoCure raised its revenue forecast from a prior range of $690M - $710M.
NovoCure has issued 11 guidance updates between January 9, 2023 and July 23, 2026. During this period, the company raised its outlook 7 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.33 | $-0.49 | $-0.41 | $-0.42 |
| Actual | $-0.13 | $-0.62 | $-0.22 | $-0.33 |
| Surprise | +60.6% | -26.5% | +46.3% | +21.4% |
| Revenue | ||||
| Estimate | $172.6M | $167.8M | $173.2M | $158.3M |
| Actual | $183.6M | $174.1M | $174.3M | $167.2M |
| Surprise | +6.35% | +3.73% | +0.67% | +5.60% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.24 | $-0.24 | $-0.20 | $-0.16 |
| Revenue | ||||
| Consensus | $182.4M | $186.2M | — | — |
